Ruifen Miao
- Molecular Biology top 10%
- Cancer Research top 1%
- Oncology
- Immunology
- Pulmonary and Respiratory Medicine
- Topics
- Tuberculosis Research and Epidemiology (6 papers)RNA modifications and cancer (6 papers)Epigenetics and DNA Methylation (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ruifen Miao
22 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 1.2k
- Cancer Research 1.1k
- Oncology 103
- Immunology 76
- Pulmonary and Respiratory Medicine 71
Countries citing papers authored by Ruifen Miao
This map shows the geographic impact of Ruifen Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruifen Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruifen Miao more than expected).
Fields of papers citing papers by Ruifen Miao
This network shows the impact of papers produced by Ruifen Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruifen Miao. The network helps show where Ruifen Miao may publish in the future.
Co-authorship network of co-authors of Ruifen Miao
This figure shows the co-authorship network connecting the top 25 collaborators of Ruifen Miao. A scholar is included among the top collaborators of Ruifen Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruifen Miao. Ruifen Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 13 | |
| 5 | 16 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | 11 | |
| 9 | 23 | |
| 10 | 13 | |
| 11 | 49 | |
| 12 | 38 | |
| 13 | 23 | |
| 14 | 9 | |
| 15 | Genetic variants of miRNA sequences and non–small cell lung cancer survivalbreakdown → | 512 |
| 16 | 9 | |
| 17 | 46 | |
| 18 | 330 | |
| 19 | 35 | |
| 20 | 34 |
About Ruifen Miao
Ruifen Miao is a scholar working on Cancer Research, Infectious Diseases and Immunology, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), RNA modifications and cancer (6 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.2k citations) and Oncology (103 citations). Ruifen Miao has collaborated with scholars based in China, United States and France. Frequent co-authors include Hongbing Shen, Zhibin Hu, Tian Tian, Jiaping Chen, Xiaoyi Zhou, Guangfu Jin, Hongxia Ma, Yijiang Chen, Jie Liang and Lin Xu. Their work appears in journals such as Journal of Clinical Investigation, Clinical Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.